Evidence map›Paper›PMID 39276167›Full record

ReviewCurrent osteoporosis reports2024

PET/CT for the Opportunistic Screening of Osteoporosis and Fractures in Cancer Patients.

Peter Sang Uk Park, Thomas J Werner, Abass Alavi

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current osteoporosis reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Peter Sang Uk ParkDepartment of Radiology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA. peter.park@pennmedicine.upenn.edu.
Thomas J WernerDepartment of Radiology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
Abass AlaviDepartment of Radiology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewIn this review, we outline the different etiologies of osteoporosis in the oncologic setting and describe the basis for using PET/CT as screening tool for osteoporosis with a focus on the radiotracers [ RECENT

findingsOsteoporosis is a condition commonly affecting cancer patients due to their age, cancer-specific treatment agents, and effects of cancer. In terms of the unifying mechanism, decreased ratio of osteoblast-bone formation to osteoclast-bone resorption is responsible for causing osteoporosis. PET/CT, a crucial metabolic imaging modality in the oncologic imaging, could be a useful tool for the opportunistic screening of osteoporosis. There are two approaches with which osteoporosis could be identified with PET/CT-using either the (1) CT- based or (2) PET- based approaches. While the CT-based approach has been used with [

Indexed as

Fluorodeoxyglucose F18NeoplasmsOsteoporosisPositron Emission Tomography Computed TomographyRadiopharmaceuticalsFluorine RadioisotopesHumansOsteoporotic FracturesSodium FluorideFluorine RadioisotopesFluorodeoxyglucose F18RadiopharmaceuticalsSodium Fluoride[18F]FDG[18F]NaFCancerOpportunisticOsteoporosisPET/CT

Identifiers

PMID39276167

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.